Enhancing radiotherapy for melanoma: the promise of high-Z metal nanoparticles in radiosensitization
- PMID: 39382020
- PMCID: PMC11492696
- DOI: 10.1080/17435889.2024.2403325
Enhancing radiotherapy for melanoma: the promise of high-Z metal nanoparticles in radiosensitization
Abstract
Melanoma is a type of skin cancer that can be challenging to treat, especially in advanced stages. Radiotherapy is one of the main treatment modalities for melanoma, but its efficacy can be limited due to the radioresistance of melanoma cells. Recently, there has been growing interest in using high-Z metal nanoparticles (NPs) to enhance the effectiveness of radiotherapy for melanoma. This review provides an overview of the current state of radiotherapy for melanoma and discusses the physical and biological mechanisms of radiosensitization through high-Z metal NPs. Additionally, it summarizes the latest research on using high-Z metal NPs to sensitize melanoma cells to radiation, both in vitro and in vivo. By examining the available evidence, this review aims to shed light on the potential of high-Z metal NPs in improving radiotherapy outcomes for patients with melanoma.
Keywords: gold nanoparticle; high-Z material; melanoma; radiosensitization; radiotherapy.
Plain language summary
[Box: see text].
Conflict of interest statement
The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Similar articles
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article.
-
GRPR-targeted gold nanoparticles as selective radiotherapy enhancers in glioblastoma.Phys Med Biol. 2025 Jun 20;70(12). doi: 10.1088/1361-6560/ade222. Phys Med Biol. 2025. PMID: 40480252
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
Cited by
-
Aptamers in Combination Therapies for Enhanced Radiosensitization in Cancer.Iran J Biotechnol. 2025 Jan 1;23(1):e4032. doi: 10.30498/ijb.2025.491856.4032. eCollection 2025 Jan. Iran J Biotechnol. 2025. PMID: 40463944 Free PMC article. Review.
-
Risk factors for uterine adenomyosis diagnosed by MRI in women of reproductive age.Ann Med Surg (Lond). 2025 Mar 9;87(4):1941-1946. doi: 10.1097/MS9.0000000000003175. eCollection 2025 Apr. Ann Med Surg (Lond). 2025. PMID: 40212136 Free PMC article.
-
Advances in mechanisms and challenges in clinical translation of synergistic nanomaterial-based therapies for melanoma.Front Cell Dev Biol. 2025 Jul 25;13:1648379. doi: 10.3389/fcell.2025.1648379. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40787624 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical